The CAPACITI Decision-Support Tool for National Immunization Programs

Botwright, Siobhan; Giersing, Birgitte; Meltzer, Martin I.; Kahn, Anna-Léa; Jit, Mark; Baltussen, Rob; Omeiri, Nathalie El; Biey, Joseph; Moore, Kelly L.; Thokala, Praveen; Mwenda, Jason M.; Bertram, Melanie; Hutubessy, Raymond

doi:10.1016/j.jval.2021.04.1273

Cited by 13 publications

(12 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, a recent study by WHO encouraged weighting and scoring as they help streamline the deliberative discussions. 47 The methods used in our study, where the stakeholders deliberated the results from the quantitative MCDA and the performance matrix before finalising the ranking of vaccines, are in line with these recommendations.…”

Section: Discussionmentioning

confidence: 99%

Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study

et al. 2022

Self Cite

View full text Add to dashboard Cite

ObjectiveTo prioritise vaccines for introduction in Bangladesh.MethodsMulticriteria decision analysis (MCDA) process was used to prioritise potential vaccines for introduction in Bangladesh. A set of criteria were identified, weighted and assigned scores by relevant stakeholders (n=14) during workshop A. The performance matrix of the data of vaccines against the criteria set was constructed and validated with the experts (n=6) in workshop B. The vaccines were ranked and appraised by another group of stakeholders (n=10) in workshop C, and the final workshop D involved the dissemination of the findings to decision-makers (n=28).ResultsFive criteria including incidence rate, case fatality rate, vaccine efficacy, size of the population at risk and type of population at risk were used quantitatively to evaluate and to score the vaccines. Two other criteria, cost-effectiveness and outbreak potentiality, were considered qualitatively. On deliberation, the Japanese encephalitis (JE) vaccine was ranked top to be recommended for introduction in Bangladesh.ConclusionsBased on the MCDA results, JE vaccine is planned to be recommended to the decision-makers for introduction into the national vaccine benefit package. The policymakers support the use of systematic evidence-based decision-making processes such as MCDA for vaccine introduction in Bangladesh, and to prioritise health interventions in the country.

show abstract

Section: Discussionmentioning

confidence: 99%

Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…The management of COVID-19 spread in crisis situations is challenge [37]. Additionally, national and global health organizations (e.g., WHO, UNICEF, and CDC) have consistently recommended national governments to use various measures to curb the spread of COVID-19 and devise effective treatment protocols and strategies [68,69]. However, national treatment and immunization programs must be trained to elucidate global guidelines and make decisions best suited to their context.…”

Section: Disease-related Issuesmentioning

confidence: 99%

Systematic review of MCDM approach applied to the medical case studies of COVID-19: trends, bibliographic analysis, challenges, motivations, recommendations, and future directions

Alamoodi

Zaidan

Albahri

et al. 2023

Complex Intell. Syst.

View full text Add to dashboard Cite

When COVID-19 spread in China in December 2019, thousands of studies have focused on this pandemic. Each presents a unique perspective that reflects the pandemic’s main scientific disciplines. For example, social scientists are concerned with reducing the psychological impact on the human mental state especially during lockdown periods. Computer scientists focus on establishing fast and accurate computerized tools to assist in diagnosing, preventing, and recovering from the disease. Medical scientists and doctors, or the frontliners, are the main heroes who received, treated, and worked with the millions of cases at the expense of their own health. Some of them have continued to work even at the expense of their lives. All these studies enforce the multidisciplinary work where scientists from different academic disciplines (social, environmental, technological, etc.) join forces to produce research for beneficial outcomes during the crisis. One of the many branches is computer science along with its various technologies, including artificial intelligence, Internet of Things, big data, decision support systems (DSS), and many more. Among the most notable DSS utilization is those related to multicriterion decision making (MCDM), which is applied in various applications and across many contexts, including business, social, technological and medical. Owing to its importance in developing proper decision regimens and prevention strategies with precise judgment, it is deemed a noteworthy topic of extensive exploration, especially in the context of COVID-19-related medical applications. The present study is a comprehensive review of COVID-19-related medical case studies with MCDM using a systematic review protocol. PRISMA methodology is utilized to obtain a final set of (n = 35) articles from four major scientific databases (ScienceDirect, IEEE Xplore, Scopus, and Web of Science). The final set of articles is categorized into taxonomy comprising five groups: (1) diagnosis (n = 6), (2) safety (n = 11), (3) hospital (n = 8), (4) treatment (n = 4), and (5) review (n = 3). A bibliographic analysis is also presented on the basis of annual scientific production, country scientific production, co-occurrence, and co-authorship. A comprehensive discussion is also presented to discuss the main challenges, motivations, and recommendations in using MCDM research in COVID‐19-related medial case studies. Lastly, we identify critical research gaps with their corresponding solutions and detailed methodologies to serve as a guide for future directions. In conclusion, MCDM can be utilized in the medical field effectively to optimize the resources and make the best choices particularly during pandemics and natural disasters.

show abstract

“…To have sufficient validity, these consultations should comprise multi-country indepth analyses that involve national opinion leaders, policymakers, and finance officials, as well as selected health care providers. These could include structured or semi-structured interviews, open-ended or discrete choice surveys, formal and informal consultations of many kinds, and successful examples exist for other pathogens [35,36]. Such analyses could also be useful to better understand what LMIC stakeholders consider to be the optimal schedule for a Shigella vaccine.…”

Section: Further Efforts To Better Understand the Value Of Shigella V...mentioning

confidence: 99%

“…What LMIC stakeholders think Systematic consultation with stakeholders [35,36] Ultimate deciders of vaccine prioritization and introduction…”

Section: Prospect Of a Healthy Competitive And Sustainable Vaccine Ma...mentioning

confidence: 99%

What Drives the Value of a Shigella Vaccine?

2022

Self Cite

View full text Add to dashboard Cite

The development and licensure of a safe and highly efficacious Shigella vaccine has been a priority in international public health circles for decades and would represent a great scientific achievement. Nonetheless, in the context of increasingly crowded and costly childhood immunization programs, and with a myriad of other new and improved vaccines currently or soon on the market, there is no guarantee that even a highly effective Shigella vaccine would become a priority for adoption and introduction by the low- and middle-income countries that could benefit from it the most. We discuss here some of the major determinants and questions regarding the introduction of Shigella vaccines and the importance of developing a succinct, compelling public health value proposition.

show abstract

The CAPACITI Decision-Support Tool for National Immunization Programs

Cited by 13 publications

References 23 publications

Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study

Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study

Systematic review of MCDM approach applied to the medical case studies of COVID-19: trends, bibliographic analysis, challenges, motivations, recommendations, and future directions

What Drives the Value of a Shigella Vaccine?

Contact Info

Product

Resources

About